As of Jun 24
| -0.41 / -6.97%|
The 4 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 13.00 and a low estimate of 4.75. The median estimate represents a +91.96% increase from the last price of 5.47.
The current consensus among 4 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.